Go to content
UR Home

Advances in the therapy of high-grade glioma at relapse: pegylated liposomal doxorubicin

Hau, Peter, Dietrich, Joerg, Fabel, Klaus and Bogdahn, Ulrich (2002) Advances in the therapy of high-grade glioma at relapse: pegylated liposomal doxorubicin. Expert review of neurotherapeutics 2 (5), pp. 609-615.

Full text not available from this repository.

at PubMed

at publisher (via DOI)


Abstract

Approaches to improve the prognosis of patients with high-grade glioma, which is still grim despite combined therapy and major advances in the development of new drugs, are highly important. Chemotherapeutic agents have not consistently produced favorable results in the relapse setting so far, with tumor responses reported in a minority of cases. Among them, doxorubicin has not shown significant ...

plus


Export bibliographical data



Item type:Article
Date:2002
Institutions:Medicine > Zentren des Universitätsklinikums Regensburg > Zentrum für Hirntumore (ZHT)
Identification Number:
ValueType
19810975PubMed ID
10.1586/14737175.2.5.609DOI
Dewey Decimal Classification:600 Technology > 610 Medical sciences Medicine
Status:Published
Refereed:Yes, this version has been refereed
Created at the University of Regensburg:Yes
Item ID:29348
Owner only: item control page
  1. Homepage UR

University Library

Publication Server

Contact:

Publishing: oa@ur.de

Dissertations: dissertationen@ur.de

Research data: daten@ur.de

Contact persons